Sareum Holdings plc (SAR.L)

LSE • Currency in GBP

£18.00

£0.00

0.00%

Last Update: 17 Jul 2025, 16:07

£24.19M

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

£11.00 - £38.00

52 Week Range

SAR.L Stock Price Chart

Explore Sareum Holdings plc interactive price chart. Choose custom timeframes to analyze SAR.L price movements and trends.

There is nothing to show.

SAR.L Company Profile

Discover essential business fundamentals and corporate details for Sareum Holdings plc (SAR.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

11 Oct 2004

Employees

5.00

Website

https://www.sareum.com

CEO

Stephen Barry Parker DPhil,

Description

Sareum Holdings plc, a specialist drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. It has collaborations with Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. The company was founded in 2003 and is based in Cambridge, the United Kingdom.

SAR.L Financial Timeline

Browse a chronological timeline of Sareum Holdings plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 23 Mar 2026

Upcoming earnings on 27 Oct 2025

Earnings released on 25 Mar 2025

EPS came in at -£0.01.

Earnings released on 29 Oct 2024

EPS came in at -£0.01.

Earnings released on 28 Mar 2024

EPS came in at -£0.04.

Earnings released on 9 Oct 2023

EPS came in at -£0.03.

Earnings released on 22 Mar 2023

EPS came in at -£0.02.

Earnings released on 30 Jun 2022

EPS came in at -£0.02.

Stock split effective on 1 Mar 2022

Shares were split 1:50, changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Dec 2021

EPS came in at -£0.01.

Earnings released on 30 Jun 2021

EPS came in at -£0.01.

Earnings released on 31 Dec 2020

EPS came in at -£0.01.

SAR.L Stock Performance

Access detailed SAR.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.